Association of a body shape index with cardiovascular risk profile in subjects with type 2 diabetes mellitus: an observational hospital-based study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250933Keywords:
A body shape index, T2DM, Cardiovascular riskAbstract
Background: A body shape index (ABSI), has been shown to be a better predictor of all-cause mortality in incident hypertension, diabetes mellitus (DM) and cardiovascular diseases (CVDs). However, few studies explore association between ABSI and cardiovascular risk profile in patients with DM.
Methods: This was an observational, hospital-based study conducted in the medical outpatient clinic of a tertiary-care center in Northern India. The study included diagnosed cases of type 2 DM (T2DM) (1:1 male-female ratio, aged ≥35 years). Anthropometric indices assessed included ABSI, WC, and body mass index (BMI). Primary outcome measures were HbA1c, systolic and diastolic blood pressure (SBP and DBP), and serum triglycerides (TG). The secondary outcome was urine albumin-to-creatinine ratio (UACR). Correlations between ABSI and cardiovascular risk factors were analyzed, and receiver operating characteristic (ROC) curve analysis was performed to compare the predictive ability of ABSI against WC and BMI.
Results: No significant positive correlation was found (all p>0.05). Weak positive and negative correlations were observed between ABSI and HbA1c, TG and systolic blood pressure, UACR respectively. A significant negative correlation (p<0.05) was observed between ABSI and diastolic blood pressure (r=-0.243, p=0.023) in males. On assessment of area under curve (AUC) of ROC, ABSI, fared better than WC and BMI in association with HbA1c, TG, and blood pressure.
Conclusions: Our study showed that there was no conclusive evidence to support ABSI as an accurate tool to gauge cardiovascular risks in patients with T2DM.
Metrics
References
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-34. DOI: https://doi.org/10.1016/S0140-6736(23)01301-6
Brown AF, Ettner SL, Piette J, Morris W, Edward G, Martin FS, et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev. 2004;26:63. DOI: https://doi.org/10.1093/epirev/mxh002
Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Sinem K, et al. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts. 2019;12(2):167-78. DOI: https://doi.org/10.1159/000496624
Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Brit J Radiol. 2012;85(1009):1-10. DOI: https://doi.org/10.1259/bjr/38447238
Mooradian AD. Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines. Arch Intern Med. 2003;163(1):33-40. DOI: https://doi.org/10.1001/archinte.163.1.33
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovascular Diabetol. 2018;17(1):83. DOI: https://doi.org/10.1186/s12933-018-0728-6
Cusick M, Meleth AD, Agron E, Fisher MR, Reed GF, Knatterud GL, et al. Associations of Mortality and Diabetes Complications in Patients with Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27. Diabetes Care. 2005;28(3):617-25. DOI: https://doi.org/10.2337/diacare.28.3.617
Du T, Sun X, Huo R, Yu X. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes (Lond). 2014;38(6):840-7. DOI: https://doi.org/10.1038/ijo.2013.181
Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 2011;36(2):286-94. DOI: https://doi.org/10.1038/ijo.2011.100
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34(5):791-9. DOI: https://doi.org/10.1038/ijo.2010.5
Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, et al. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 2013;21(1):E154-61. DOI: https://doi.org/10.1002/oby.20263
Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7:e39504. DOI: https://doi.org/10.1371/journal.pone.0039504
Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, et al. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr. 2013;67(12):1298-302.
Dhana K, Kavousi M, Ikram MA, Tiemeier HW, Hofman A, Franco OH. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J Epidemiol Community Health. 2016;70(1):90-6. DOI: https://doi.org/10.1136/jech-2014-205257
Kajikawa M, Maruhashi T, Kishimoto S, Takayuki Y, Takahiro H, Yu H, et al. A body shape index is associated with endothelial dysfunction in both men and women. Sci Rep. 2021;11(1):17873. DOI: https://doi.org/10.1038/s41598-021-97325-0
Ranasinghe P, Jayawardena R, Gamage N, Sivanandam N, Misra A. Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol. 2021;58:128-48. DOI: https://doi.org/10.1016/j.annepidem.2021.02.016
Al-Goblan, Abdullah S, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes, metabolic syndrome and obesity: targets and therapy. Diabetes Metab Syndr Obes. 2014;7:587-91. DOI: https://doi.org/10.2147/DMSO.S67400
Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a re-evaluation. Diabetes. 2011;60(10):2441-9. DOI: https://doi.org/10.2337/db11-0425
Jelic K, Luzio SD, Dunseath G, Colding-Jorgsensen M, Owens DR. A cross-sectional analysis of NEFA levels following standard mixed meal in a population of persons with newly diagnosed type 2 diabetes mellitus across a spectrum of glycemic control Alexandria, VA: American Diabetes Association. 2007.
Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246-58. DOI: https://doi.org/10.4239/wjd.v6.i13.1246
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34. DOI: https://doi.org/10.1056/NEJM199807233390404
Kai W, He S, Zheng Y, Chen X. ABSI is a poor predictor of insulin resistance in Chinese adults and elderly without diabetes. Arch Endocrinol Metabolism. 2018;62(5):523-9. DOI: https://doi.org/10.20945/2359-3997000000072
Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, et al. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr. 2013;67(12):1298-302. DOI: https://doi.org/10.1038/ejcn.2013.203
Behboudi-Gandevani S, Tehrani FR, Rahmati M, Amiri M, Azizi F. Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study. BMC Endocr Disord. 2019;19(1):24. DOI: https://doi.org/10.1186/s12902-019-0348-5
Haghighatdoost F, Sarrafzadegan N, Mohammadifard N, Asgary S, Boshtam M, Azadbakht L. Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. Nutrition. 2014;30(6):636-44. DOI: https://doi.org/10.1016/j.nut.2013.10.021
Downloads
Published
How to Cite
Issue
Section
